Showing results (41-50 of 266) with videos related to
Sort By:
Pageof 27
Nanomedicine (London, England)|August 26, 2016
Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse modelsMohamad Hadla, Stefano Palazzolo, Giuseppe Corona, et al.Dalton Transactions (Cambridge, England : 2003)|December 8, 2025
Palladium(0) and Juglone: a new alliance in the fight against ovarian cancerGiovanni Tonon, Anna Rafaniello, Matteo Mauceri, et al.Methods in Molecular Biology (Clifton, N.J.)|July 25, 2018
Rational Development of MAGL InhibitorsCarlotta Granchi, Flavio Rizzolio, Isabella Caligiuri, et al.Current Medicinal Chemistry|December 30, 2017
Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to ClinicSamer Bayda, Mohamad Hadla, Stefano Palazzolo, et al.Expert Opinion on Therapeutic Patents|October 21, 2020
An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present)Giulia Bononi, Giulio Poli, Flavio Rizzolio, et al.Molecules (Basel, Switzerland)|March 13, 2024
Platinum(0)-η2-1,2-(E)ditosylethene Complexes Bearing Phosphine, Isocyanide and N-Heterocyclic Carbene Ligands: Synthesis and Cytotoxicity towards Ovarian and Breast Cancer CellsNicola Compagno, Rachele Piccolo, Enrica Bortolamiol, et al.Current Medicinal Chemistry|September 7, 2017
The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and ExosomesStefano Palazzolo, Samer Bayda, Mohamad Hadla, et al.Nanoscale|June 8, 2021
Protection against proteolysis of a targeting peptide on gold nanostructuresFrancesca Biscaglia, Isabella Caligiuri, Flavio Rizzolio, et al.RSC Advances|April 28, 2022
Sustainable triazine-derived quaternary ammonium salts as antimicrobial agentsAndrea Morandini, Emanuele Spadati, Benedetta Leonetti, et al.Frontiers in Medicine|December 6, 2019
Big Data in Medicine, the Present and Hopefully the FutureMichela Riba, Cinzia Sala, Daniela Toniolo, et al.Pageof 27